ELMS STEVE
SEC CIK 1250195 · EDGAR
BoughtSold
Most active insiders at ADMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grossman Adam S | Pres, CEO, Dir | — | $1.74M |
| 2 | Grossman Jerrold B | Dir | $250.9K | — |
| 3 | ELMS STEVE | Dir | $217.4K | — |
| 4 | Kestenberg-Messina Kaitlin M. | COO, SVP, Compliance | — | $157.8K |
| 5 | Tade Brad L. | CFO, Treas | — | — |
| 6 | Salas Eduardo Rene | Dir | — | — |
| 7 | Kohler Terry | CFO, Treas | — | — |
| 8 | KWON YOUNG | Dir | — | — |
| 9 | FINGER ALISON CECILY | Dir | — | — |
| 10 | Guiheen Lawrence P. | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-03-09 | 2026-03-05+ | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | P - Purchase | $15.53 | +14.0K | 2.05M | +0.7% | +$217.4K |
| D | 2026-02-11 | 2026-02-09 | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | A - Grant | $0.00 | +10.7K | 98.0K | +12% | $0 |
| DM | 2025-06-16 | 2025-06-13 | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | M - OptEx | $3.43 | +332.7K | 207.7K | New | +$1.14M |
| DM | 2025-06-16 | 2025-06-13+ | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | S - Sale+OE | $20.48 | -332.7K | 282.1K | -54% | -$6.81M |
| DI | 2025-06-16 | 2025-06-12 | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | S - Sale+OE | $21.69 | -92.9K | 2.03M | -4% | -$2.02M |
| D | 2025-02-21 | 2025-02-19 | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | A - Grant | $0.00 | +10.9K | 87.3K | +14% | $0 |
| I | 2024-12-26 | 2024-12-23 | MRKR | Marker Therapeutics, Inc. | ELMS STEVE | Dir | P - Purchase | $3.20 | +11.1K | 325.4K | +4% | +$35.5K |
| DI | 2024-12-02 | 2024-11-27 | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | M - OptEx | $10.80 | +9,000 | 2.12M | +0.4% | +$97.2K |
| MI | 2024-03-19 | 2024-03-18+ | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | S - Sale | $6.07 | -461.7K | 2.53M | -15% | -$2.80M |
| MI | 2024-03-15 | 2024-03-13+ | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | S - Sale | $6.11 | -1.04M | 3.21M | -24% | -$6.34M |
| D | 2024-02-28 | 2024-02-26 | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | A - Grant | $0.00 | +24.0K | 76.4K | +46% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | A - Grant | $0.00 | +25.8K | 52.4K | +97% | $0 |
| D | 2022-03-09 | 2022-03-07 | ADMA | ADMA BIOLOGICS, INC. | ELMS STEVE | Dir | A - Grant | $0.00 | +26.6K | 26.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations